RxS

What RxS does

RxS is a multichannel sample management company that served pharmaceutical and life science companies prior to its acquisition by Medvantx on July 8, 2025. Founded in 2011 and headquartered in Manalapan, New Jersey, RxS focused on broadening integrated access and engagement solutions for life science firms, with stated capabilities spanning patient assistance, telehealth, omnichannel engagement, and regulatory compliance related to pharmaceutical sampling. The company's core offering centered on distributing and monitoring drug samples across multiple channels — including hand-carry and direct-to-provider pathways — within a compliance framework suited to life science manufacturer needs. No detailed technical specifications of RxS's underlying platform, proprietary algorithms, or data architecture are publicly disclosed.

Pre-acquisition, RxS operated as an independent private firm with 11-50 employees, functioning as a B2B service provider to life science manufacturers. Its business model relied on engagements with pharma and life science companies for sample management services, though specific pricing models, contract structures, and revenue mechanics are not publicly disclosed. There is no documented funding history or investor base for RxS as a standalone entity.

Following the July 2025 acquisition, RxS was absorbed into Medvantx, a pharmacy services platform offering patient assistance programs, cash pay, central fill pharmacy, telehealth, and product compliance solutions underpinned by the proprietary Medvantx Insights Platform. Post-acquisition, RxS's multichannel sample management capabilities are positioned alongside Medvantx's broader service portfolio, including ACHC-accredited, NABP Digital Pharmacy-certified mail order pharmacy operations and LegitScript-verified digital pharmacy compliance. The combined entity targets drug manufacturers seeking integrated access and engagement solutions, but no consolidated post-deal revenue or operational metrics are provided in the input.

Name

RxS

Legal name

RxS

Website

https://rxsinfo.com

Company type

Private

Founded year

2011

Operating status

Acquired

Headcount range

101–250 employees

Short description

RxS was a multichannel sample management company serving pharmaceutical and life science manufacturers with integrated access and engagement solutions spanning sampling, compliance, and patient support. The company was acquired by Medvantx on July 8, 2025.

Ownership category

akta.pro rank

Product category

Pharmaceutical Sample Management Services

NAICS

Management Consulting Services (54161)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

• Multichannel sample management
• Pharmaceutical sampling services
• Drug sample distribution
• Life science compliance
• Sample program administration

Headquarters

HQ city

Manalapan

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Core offering

RxS provides end-to-end multichannel sample management solutions for pharmaceutical and life science companies. The company enables drug manufacturers to distribute and monitor product samples through multiple channels including hand-carry and direct-to-provider distribution while maintaining full regulatory compliance. Following its July 2025 acquisition by Medvantx, RxS's sample management capabilities are integrated with Medvantx's broader pharmacy, patient assistance, telehealth, and omnichannel engagement services.

Product overview

Medvantx operates as a pharmacy services platform offering a portfolio of interconnected services enabled by its proprietary Medvantx Insights Platform. The core offerings include Patient Assistance Programs (PAPs), Cash Pay, Pharmacy Services, Telehealth, Central Fill Pharmacy, and Sampling Programs. The platform also includes Medvantx Kitting Solutions, Product Replacement, Inside Sales Solutions, and Hospital Free Trial Programs. RxS, a multichannel sample management company, was acquired to broaden integrated access and engagement solutions. All services are designed to connect patients, providers, and healthcare manufacturers to enhance medication access and improve health outcomes.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• MedvantxcoreStrategic or Co-development Partner · 8 July 2025Medvantx acquired RxS to broaden integrated access and engagement solutions for life science companies. The combined entity enhances capabilities including patient assistance, telehealth, omnichannel engagement, and regulatory compliance.

Recent moves1 record

Expansion highlights3 records

Direct peers

• Ashfield (Inizio): Global pharma commercial-services provider delivering patient access, sampling, HCP engagement, and inside-sales services — directly overlapping with RxS's multichannel sample management and post-acquisition Medvantx portfolio.
• EVERSANA: End-to-end commercial-services platform for pharma manufacturers offering patient services, sample management, hub, and distribution — closely comparable to RxS's life-science sample management focus.
• Amplity Health: Commercial services firm that delivers in-person and remote HCP engagement, inside sales, and patient access programs — comparable to RxS's multichannel sample distribution and inside-sales capability.

Broad incumbents

• IQVIA: Largest commercial life-science services platform spanning real-world evidence, patient access, sampling, and fulfillment — broader incumbent that competes for similar pharma manufacturer budgets as RxS/Medvantx.
• Syneos Health: Large biopharma solutions organization offering clinical and commercial services including patient access and HCP engagement programs; competes with RxS in adjacent manufacturer service lines.
• Cencora (AmerisourceBergen): Major pharmaceutical distributor with manufacturer-services offerings spanning sampling, patient assistance, and specialty distribution — broad incumbent that competes for pharma sampling and access budget.
• McKesson: Top-tier pharmaceutical distributor offering manufacturer services, sample distribution, and patient support programs; comparable as a scaled player in the same value chain RxS serves.
• Cardinal Health: Pharma distributor and manufacturer-services provider with sample-management capabilities and home-care/specialty offerings; overlaps with RxS in pharma sampling and access programs.

Emerging players

• Precisioneffect: HCP-focused commercial agency delivering sampling, inside sales, and engagement programs for emerging and mid-size pharma — closely comparable to RxS's targeted-sample-and-engagement offering.

Others

• Loftware (sample labeling/compliance): Provider of regulated sample labeling, serialization, and compliance software for pharma/life sciences — enabling technology layer adjacent to RxS's sampling workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxS